A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

NCT02928393 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Low participant enrolment

Conditions

Stroke

Interventions

DRUG: Basmisanil
DRUG: Placebo

Sponsor

Hoffmann-La Roche